Companies / Achillion Pharmaceuticals Inc
Achillion Pharmaceuticals Inc
ACHNCIK 1070336
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Sep 30, 2013 | Ra Capital Management, LLC 10% owner | Buy Open-market buy | Common Stock, $0.001 par value | $5.43M | +1.6M +47.54% | 4,816,562 | high |
| Sep 27, 2013 | Ra Capital Management, LLC 10% owner | Buy Open-market buy | Common Stock, $0.001 par value | $1.60M | +400K +8.30% | 5,216,562 | high |
| Jan 21, 2015 | Deshpande Milind CEO | Sell Open-market sale | Common Stock | $1.50M | -100K -100.00% | 0 | medium |
| Sep 25, 2013 | Ra Capital Management, LLC 10% owner | Sell Open-market sale | Common Stock, $0.001 par value | $985.9K | -136K -2.51% | 5,280,762 | medium |
| Sep 27, 2013 | Ra Capital Management, LLC 10% owner | Buy Open-market buy | Common Stock, $0.001 par value | $800.0K | +200K +3.83% | 5,416,562 | high |
| Aug 26, 2013 | Ra Capital Management, LLC 10% owner | Buy Open-market buy | Common Stock, $0.001 par value | $759.4K | +116K +2.30% | 5,137,117 | high |
| Sep 16, 2013 | Ra Capital Management, LLC 10% owner | Sell Open-market sale | Common Stock, $0.001 par value | $690.9K | -92K -1.85% | 4,867,617 | medium |
| Sep 17, 2013 | Ra Capital Management, LLC 10% owner | Sell Open-market sale | Common Stock, $0.001 par value | $576.0K | -78K -1.54% | 4,959,418 | medium |